ΠΠΎΠ΄Ρ ΠΎΠ΄Ρ ΠΊ ΠΌΠΎΠ΄Π΅Π»ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΈΠΌΠΌΡΠ½ΠΎΠ³Π΅Π½Π½ΡΡ ΠΏΠ΅ΠΏΡΠΈΠ΄ΠΎΠ²
ΠΡΡΠ³ΠΈΠΌ ΠΏΠΎΠ΄Ρ ΠΎΠ΄ΠΎΠΌ ΠΊ ΠΌΠΎΠ΄Π΅Π»ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΈΠΌΠΌΡΠ½ΠΎΠ³Π΅Π½Π½ΡΡ ΠΏΠ΅ΠΏΡΠΈΠ΄ΠΎΠ² ΡΠ²Π»ΡΠ΅ΡΡΡ ΡΠΎΠ·Π΄Π°Π½ΠΈΠ΅ ΠΏΠ΅ΠΏΡΠΈΠ΄Π½ΡΡ ΠΊΠΎΠ½ΡΡΡΡΠΊΡΠΈΠΉ, Π²ΠΊΠ»ΡΡΠ°ΡΡΠΈΡ ΠΈΠ·Π²Π΅ΡΡΠ½ΡΠ΅ Π-ΠΊΠ»Π΅ΡΠΎΡΠ½ΡΠ΅ ΠΈ Π’-Ρ Π΅Π»ΠΏΠ΅ΡΠ½ΡΠ΅ ΡΠΏΠΈΡΠΎΠΏΡ Π±Π΅Π»ΠΊΠ°, Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΠΊΠΎΡΠΎΡΡΡ ΠΌΠΎΠΆΠ½ΠΎ ΠΈΠΌΠΈΡΠΈΡΠΎΠ²Π°ΡΡ ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ ΠΏΡΠΎΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠ³ΠΎ ΠΈΠΌΠΌΡΠ½ΠΈΡΠ΅ΡΠ° ΠΊ ΡΠ°Π·Π»ΠΈΡΠ½ΡΠΌ ΠΏΠ°ΡΠΎΠ³Π΅Π½Π°ΠΌ. ΠΠ»Ρ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΡΡΠΎΠ³ΠΎ ΠΏΠΎΠ΄Ρ ΠΎΠ΄Π° Π½Π΅ΠΎΠ±Ρ ΠΎΠ΄ΠΈΠΌΡ Π·Π½Π°Π½ΠΈΡ ΠΎ Π»ΠΎΠΊΠ°Π»ΠΈΠ·Π°ΡΠΈΠΈ ΠΈΠΌΠΌΡΠ½ΠΎΠ°ΠΊΡΠΈΠ²Π½ΡΡ ΡΡΠ°ΡΡΠΊΠΎΠ² Π² Π°ΠΌΠΈΠ½ΠΎΠΊΠΈΡΠ»ΠΎΡΠ½ΡΡ ΠΏΠΎΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΠΎΡΡΡΡ Π±Π΅Π»ΠΊΠΎΠ² ΠΈΠ·ΡΡΠ°Π΅ΠΌΠΎΠ³ΠΎ ΠΏΠ°ΡΠΎΠ³Π΅Π½Π°… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- Francis M.J. in New generation vaccines: The role of basic immunology Eds G.
- Gregoriadis, B. McCormack, A.C. Allison and G. Poste (Plenum Press, NY), 1993, p.23.
- Steward M.W., Stanley C.M., Dimarchi R., Mulcahy G., Doel T.R. High-affinity antibodyinduced by immunization with a synthetic peptide is associated with protection of cattle against foot-and-mouth disease. // Immunology, 1991, v.12, p.99.
- Sood A., Venugopalan P., Mysore N. and Vyas S.P. Synthetic peptides: A modernapproach to vaccination. // Indian J. Exp. Biol., 1998, v. 35, p. 846−861.
- Townsend A.R.M. Recognition of influenza virus proteins by cytotoxic T lymphocytes. //1.munol. Res. 1987. V. 6. № 1−2. P. 80−100.
- Ben-Yedidia T. and Arnon R. Design of peptide and polypeptide vaccines. // Curr. Opin.
- Biotechol., 1997, v. 8, p. 442−448.
- Brodsky F.M., Guagliardi L. The cell biology of antigen processing and presentation. //
- Annu. Rev. Immunol., 1991, v. 9, p. 707−44
- Barber L.D. and Parham P. Peptide binding to major histocompatibility complexmolecules. //Annu. Rev. Cell Biol., 1993, v. 9, p. 163−206.
- ΠΠ΅ΡΡΠΎΠ² P.B. ΠΠΌΠΌΡΠ½ΠΎΠ»ΠΎΠ³ΠΈΡ, M., «ΠΠ΅Π΄ΠΈΡΠΈΠ½Π°», 1983, Ρ.
- Π.Π. Π―ΡΠΈΠ»ΠΈΠ½. ΠΡΠ½ΠΎΠ²Ρ ΠΈΠΌΠΌΡΠ½ΠΎΠ»ΠΎΠ³ΠΈΠΈ. M. «ΠΠ΅Π΄ΠΈΡΠΈΠ½Π°». 1999
- Madden D. R The three-dimensional structure of peptide-ΠΠΠ‘ complexes. // Annu. Rev. Immunol., 1995, v. 13, p. 587−622.
- Π ΠΎΠΉΡ Π., ΠΡΠΎΡΡΠΎΡΡ ΠΠΆ., ΠΠ΅ΠΉΠ» Π. ΠΠΌΠΌΡΠ½ΠΎΠ»ΠΎΠ³ΠΈΡ, Π., «ΠΠΈΡ», 2000, Ρ. 195−215.
- Cresswell P. Assembly, transport, and function of ΠΠΠ‘ class Π molecules. // Annu. Rev. Immunol., 1994, v. 12, p. 252−293.
- Mouritsen S., Meldal M., Werdelin O., Hansen A.S., Buus S. MHC molecules protect T cell epitopes against proteolytic destruction. //J. Immunol., 1992, v. 149, p. 1987−1993.
- Janeway C.A.J, and Travers P., Eds. Immunobiology: the immune system in health and disease. Curr. Biol. Ltd./Garland Publ. Inc., 1994.
- Babbit B.P., Allen P.M., Matsueda G., Harber E., Unanue E.R. Binding of immunogenic peptides to la histocompatibility molecules. // Nature, 1985, v. 312, p. 359.
- Rosental A.S. Determinant selection and macrophage function in genetic control of the immune response. // Immunol. Rev., 1978, v. 40, p. 136.
- Abbas A.K. A reassessment of the mechanisms of antigen-specific T-cell-depended B-cell activation. // Immunol. Today, 1988, v. 9, p. 89−94.
- Hoop T. and Woods K. Prediction of protein antigenic determinants from aminoacid seqences. // Proc. Natl. Acad. Sci. USA, 1981, v. 78, p. 3824−3828.
- Welling G., Weijer W., Zee R. and Welling-Wester S. Prediction of sequential antigenic regions in proteins. // FEBS Lett., 1985, v. 188, p. 215−218.
- Hoop T. Prediction of protein surfaces and interaction sites from amino acid sequences.
- Synthetic Peptides in Biology and Medicine, Eds K. Alitalo, P. Partanen, A. Vahery,
- Amsterdam, Elsevier Science Publishers, 1985, p. 3−11.
- Novotny J., Handschumacher M., Harber E. Location of antigenic epitopes on antibody molecules. // Proc. Natl. Acad. Sci. USA., 1986, v.83, p. 226−230.
- ΠΠ²ΡΡΠΈΠ³Π½Π΅Π΅Π²Π° P., ΠΠ°Π»ΡΠΊΠ΅Π΅Π²Π° M. ΠΠ΅ΡΠΎΠ΄Ρ ΠΏΠΎΠΈΡΠΊΠ° Π°Π½ΡΠΈΠ³Π΅Π½Π½ΡΡ Π΄Π΅ΡΠ΅ΡΠΌΠΈΠ½Π°Π½Ρ Π΄Π»Ρ Π±Π΅Π»ΠΊΠΎΠ² Ρ ΠΈΠ·Π²Π΅ΡΡΠ½ΠΎΠΉ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎΠΉ ΡΡΡΡΠΊΡΡΡΠΎΠΉ. // ΠΠΈΠΎΠΎΡΠ³Π°Π½ΠΈΡΠ΅ΡΠΊΠ°Ρ Ρ ΠΈΠΌΠΈΡ, 2000, № 26, Ρ. 243−262.
- Stern L.J. and Wiley D.C. Antigenic peptide binding by class I and class Π histocompatibility proteins. // Structure, 1994, v. 2, p. 245−251.
- Stern L.J., Brown J.H., Jardetzky T.S., Gorga J.C., Urban R.G., Strominger J.L., Wiley D.C. Crystal structure of the human class Π MHC protein HLA-DR1 complexed with an influenza virus peptide. // Nature, 1994, v. 368, p. 215−221.
- Brown J.H., Jardetzky T.S., Gorga J.C., Stern L.J., Urban R.G., Strominger J.L., Wiley D.C. Three-dimensional structure of the human class Π histocompatibility antigen HLA-DR1. // Nature, 1993, v. 364, p. 33−39.
- Vasmatzis G., Cornette J., Sezerman U. and DeLisi C. TcR recognition of the MHC-peptide dimer: structural properties of a ternary complex. // J. Mol. Biol., 1996, v. 261, p. 72−89.
- Hare B.J., Wyss D.F., Osburne M.S., Kern P. S., Reinherz E.L., Wagner G. Conformational isomers of a class Π ΠΠΠ‘-peptide complex in solution. // J. Mol. Biol,. 1999, v. 286, p. 207−218.
- Fremont D.H., Hendrickson W.A., Marrack P. and Kappler J. Structures of an MHC class Π molecule with covalently bound single peptides. // Science, 1996, v. 272, p. 1001−1004.
- Nomenclature and Symbolism for Amino Acids and Peptides. Recommendation 1983, Eur. J. Biochem. v. 138, p. 9−37.
- Rammensee H.-G., Friede Π’., Stevanovic S. MHC ligands and peptide motifs: first listing. // Immunogen. 1995, v. 41, p. 178−228.
- Falk K., Rotzschke 0., Stevanovic S., Jung G., Rammensee H.G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. // Nature, 1991, v. 351, p. 290−296.
- Nakagawa T.Y., Von Grafenstein H., Sears J.E., Williams J., Janeway C.A., Flavell R.A. The use of the polymerase chain reaction to map CD4+ T cell epitopes. // Eur. J. Immunol., 1991, v. 21, p. 2851−2855.
- Adler S., Frank R., Lanzavecchia A. and Weiss S. T cell epitope analysis with peptides simultaneously synthesized on cellulose membranes: fine mapping of two DQ dependent epitopes. // FEBS Lett., 1994, v. 352, p. 167−170.
- Buus S., Sette A., Colon S.M., Miles C., Grey H.M. The relation between major histocompatibility complex (MHC) restriction and the capacity of la to bind immunogenic peptides. // Science, 1987, v. 235, p. 1353−1358.
- Townsend A., Ohlen C., Bastin J., Ljunggren H.G., Foster L., Karre K. Association of class I major histocompatibility heavy and light chains induced by viral peptides. // Nature, 1989, v. 340, p. 443−448.
- Moudgil K.D., Sercarz E.E. and Grewal I.S. Modulation of the immunogenicity of antigenic determinants by their flanking residues. // Immunol. Today, 1998, v. 19, p. 217−220.
- Gogolak P., Simon A., Horvath A., Rethi Π., Simon I., Berkics K., Rajnavolgyi E., Toth
- G.K. Mapping of a protective helper T cell epitope of human influenza A virus hemagglutinin. // Biochem. Biophys. Res. Commun., 2000, v. 2, p. 190−198.
- Brusic V., Rudy G., ΠΠΈΠΏΠ΅ A.P. and Harrison L.C. MHCPEP, a database of MHC-binding peptides: update 1997. // Nucleic Acids Res. 1998, v. 26, p. 368−371. http://wehih.wehi.edu.au-/mhcpep/
- DeLisi C., Berzofsky J.A. T-cell antigenic sites tend to be amphipathic structures. // Proc. Natl. Acad. Sci. USA, 1985, v. 82, p. 7048−7052.
- Berzofsky J.A. Features of T-cell recognition and antigen structure useful in the design of vaccines to elicit T-cell immunity. // Vaccine, 1988, v. 6, p. 89−93.
- Cease K.B., Margalit H., Cornette J.L., Putney S.D., Robey W.G., Ouyang C., Streicher
- Margalit H., Spouge J.L., Cornette J.L., Cease K.B., Delisi C., Berzofsky J.A. Prediction of immunodominant helper T cell antigenic sites from the primary sequence. // J. Immunol., 1987, v. 138, p. 2213−2229.
- Rothbard J.R. Synthetic peptides as vaccines // Nature, 1987, v. 330, p. 106−107.
- Rothbard J.R., Taylor W.R. A sequence pattern common to T cell epitopes. // EMBO J., 1988, v. 7, p. 93−100.
- Stille C.J., Thomas L.J., Reyes V.E., Humphreys R.E. Hydrophobic strip-of-helix algorithm for selection of T cell-presented peptides. // Mol. Immunol., 1987, v. 24, p. 1021−1027.
- Roberts C.G.P., Meister G.E., Jesdale B.M., Lieberman J., Berzofsky J.A., De Groot A.S. Prediction of HIV peptide epitopes by novel algorithm. // AIDS Res. Hum. Retroviruses, 1996, v. 12, p. 593−610.
- Cornette J.L., Margalit H., DeLisi C. and Berzofsky J.A. The amphipathic helix as a structural feature involved in T cell recognition. // The Amphipatic Helix. (Ed). CRC Press, Boca Raton, FL, 1993.
- Reyes V.E., Fowlie E.J., Lu S., Phillips L., Chin L.T., Humphreys R.E., Lew R.A. Comparison of three related methods to select T cell-presented sequences of protein antiges. // Mol. Immunol., 1990, v. 27, p. 1021−1027.
- Rammensee H.-G., Bachmann J., Emmerich N.P.N, Bachor O.A., Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. // Immunogenetics, 1999, v.50, p. 213−219. http://www.uni-tuebingen.de/uni/kxi/.
- Honeyman M.C., Brusic V., Stone N.L. and Harrison L.C. Neural network-based prediction of candidate T-cell epitopes. //Nat. Biotechnol., 1998, v. 16, p. 966−969.
- Arnon R. Synthetic peptides as basis for future vaccines. // Trens Biochem. Sci., 1986, v. 11, p. 521−524.
- Dreesman G., Sparrow J., Frenchik P., Kennedy R. Synthetic hepatitis Π surface antigen peptide vaccine. // Adv. Exp. Med. Biol., 1985, v. 185, p. 129−137.
- Emini E., Jameson Π., Wimmer E. Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides. // Nature, 1983, v. 304, p. 699−703.
- Shupp J.W., Jett M., Pontzer C.H. Identification of a transcytosis epitope on staphylococcal enterotoxins. // Infect Immun., 2002, v. 70, p. 2178−2186.
- Meng J., Dai X., Chang J.C., Lopareva E., Pillot J., Fields H.A., Khudyakov Y.E. Identification and characterization of the neutralization epitope (s) of the hepatitis E virus. // Virology, 2001, v. 30, p. 203−211.
- Wu H.C., Yeh C.T., Huang Y.L., Tarn L.J., Lung C.C. Characterization of neutralizing antibodies and identification of neutralizing epitope mimics on the Clostridium botulinum neurotoxin type A. // Appl. Environ. Microbiol., 2001, v. 67, p. 3201−3207.
- Kirkley J.E., Goldstein A.L. and Naylor P.H. Effect of peptide-carrier coupling on peptide-specific immune responses. // Immunobiology, 2001, v. 203, p. 601−615.
- Gonzalez S., Alvarez A., Caballero E., Vina L., Guillen G., Silva R. P64k meningococcal protein as immunological carrier for weak immunogens. // Scand. J. Immunol., 2000, v. 52, p.113−116.
- Lu Y., Xiao Y., Ding J., Dierich M., Chen Y.H. Immunogenicity of neutralizing epitopes on multiple-epitope vaccines against HIV-1. // Int. Arch. Allergy Immunol., 2000, v. 121, p. 80−84.
- Kim S.K., Ragupathi G., Cappello S., Kagan E., Livingston P.O. Effect of immunological adjuvant combinations on the antibody and T-cell response to vaccination with MUC1-KLH and GD3-KLH conjugates. // Vaccine, 2000, v. 15, p. 530−537.
- Laisney I.L. and Strosberg A.D. Dual specificity of a human neutralizing monoclonal antibody, specific for the V3 loop of GP120 (HIV-1). II Immunol. Lett., 1999, v. 15, p. 185−192.
- Ijaz M.K., Alkarmi Π’.Π., el-Mekki A.W., Galadari S.H., Dar F.K. Babiuk L.A. Priming and induction of anti-rotavirus antibody response by synthetic peptides derived from VP7 and VP4. // Vaccine, 1995, v. 13, p. 331−338.
- ΠΠ²Π°Π½ΠΎΠ² Π.Π., ΠΠ΅ΡΠ΅ΡΡΠΊΠΎΠ²Π° Π. Π., ΠΠ½Π΄ΡΠΎΠ½ΠΎΠ²Π° Π’. Π. ΠΈ ΠΠ²Π°Π½ΠΎΠ² Π.Π’. ΠΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠΈΠ½ΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ Π½ΠΎΡΠΈΡΠ΅Π»Π΅ΠΉ ΠΈ Π°Π΄ΡΡΠ²Π°Π½ΡΠΎΠ² Π΄Π»Ρ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΡ ΠΈΠΌΠΌΡΠ½ΠΎΠ³Π΅Π½Π½ΠΎΡΡΠΈ ΡΠΈΠ½ΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΠ΅ΠΏΡΠΈΠ΄Π° Π±Π΅Π»ΠΊΠ° CS Plasmodium falciparum. // ΠΠΈΠΎΠΎΡΠ³Π°Π½, Ρ ΠΈΠΌΠΈΡ, 1991, Ρ.17, Ρ. 732−746.
- Muller G.M., Shapira Π., Arnon R. Anti-influenza response achieved by immunization with a synthetic conjugate. // Proc. Natl. Acad. Sci. USA, 1982, v. 81, p. 2461−2465.
- Schutze M.-P., Leclerc C., Jovilet M., Audibert F., Chedid L. Carrier-induced epitopic suppression, a major issue for future synthetic vaccine. // J. Immunol., 1985, v. 135, p. 2319−2324.
- Steward M.W., Stanley C.M. and Obeid O.E. A mimotope from a solid-phase peptide library induced a measles virus- neutralizing and protective antibody response. // J. Virol., 1995, v.69, p. 7668−7673.
- Obeid O.E., Partidos C.D. and Steward M.W. Identification of helper T cell antigenic sites in mice from the heamagglutinin glycoprotein of measles virus. // J. Gen. Virol., 1993, v.74, p. 2549−2557.
- Obeid O.E., Partidos C.D. and Steward M.W. Analysis of the antigenic profile of measles virus heamagglutinin in mice and humans using overlapping synthetic peptides. // Virus Res., 1994, v.32, p. 69−84.
- Obeid O.E. and Steward M.W. The potential of immunization with synthetic peptides to overcome the immunosuppressive effect of maternal anti-measles virus antibodies in young mice. // Immunology, 1994, v.82, p. 16−21.
- Steward M.W., Partidos C.D., D’Mello F. and Howard C.R. Specificity of antibodies reactive with hepatitis ΠΈ surface antigen following immunization with synthetic peptides. //Vaccine, 1993, v. ll, p. 1405−1414.
- Shaw D.M., Stanley C.M., Partidos C.D. and Steward M.W. Influence of the T-helper epitope on the titre and affinity of antibodies to B-cell epitopes after co-immunization. // Mol. Immunol., 1993, v.30, p. 961−968.
- Sedlik C., Sarraseca J., Rueda P., Leclerc C., Casal I. Immunogenicity of poliovirus Π and T cell epitopes presented by hybrid porcine parvovirus particles. // J. Gen. Virol., 1995, v.76, p. 2361−2368.
- Francis M.J., Hastings G.Z., Syred A.D., McGinn Π., Brown F., Rowlands D.J. Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants. //Nature, 1987, v. 300, p. 168−170.
- Leclerc C., Przewlocki G., Schutze M.-P., Chedid L.A. A synthetic vaccine constructed by copolymerization of Π and T cell determinants. // Eur. J. Immunol., 1987, v. 17, p. 269−273.
- Volpina O., Surovoy A., Ivanov V. Protection against viral infections with the aid of synthetic peptides. Foot-and-mouth disease as a example. // Biomed. Sience, 1990, v. 330, p.168−170.
- Francis M.J., Fry C.M., Rowlands D.J., Bittle J.L., Houghten R.A., Lerner R.A., Brown F. Immune response to uncoupled peptides of foot-and-mouth disease virus. // Immunology, 1987, v. 61, p. 1−6.
- Hervas-Stubbs S., Berasain C., Golvano J.J., Lasarte J.J., Prieto I., Sarobe P., Prieto J., Borras-Cuesta F. Overcoming class Π-linked non-responsiveness to hepatitis Π vaccine. // Vaccine, 1994, v. 12, p. 867−871.
- Milich D.R., Hughes J.L., McLachlan A., Thornton G.B., Moriarty A. Hepatitis Π synthetic immunogen comprised of nucleocapsid T-cell sites and envelope B-cell epitope. //Proc. Natl. Acad. Sci. USA, 1988, v. 85, p. 1610−1614.
- Tam J.P. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. // Proc. Natl. Acad. Sci. USA, 1988, v. 85, p. 5409−5413.
- Tam J.P. Recent advances in multiple antigen peptides. // J. Immunol. Methods, 1996, v. 196, p. 17−32.
- Hewer R. and Meyer D. Producing a highly immunogenic synthetic vaccine construct active against HIV-1 subtype C. // Vaccine, 2002, v. 20, p. 2680−2683.
- Toth G.K., Varadi G., Nagy Z., Monostori E., Π Π΅ΠΏΠΊΠ΅ Π., Hegedus Z., Ando I., Fazekas G., Kurucz I., ΠΠ°ΠΊ M. Branched polypeptides as antigens for influenza virus hemagglutinin and T-cell receptor subunits. // Pept. Res., 1993, v. 6, p. 272−280.
- Tam J.P., Lu Y.-A. Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-cell epitopes. //Proc. Natl. Acad. Sci. USA, 1989, v. 86, p. 9084−9088.
- Pinto R.M., Gonzalez-Danaart J.F., Sanchez G., Guix S., Gomara M.J., Garcia M., Haro I., Bosch A. Enhancement of the immunogenicity of a synthetic peptide bearing a VP3 epitope of hepatitis A virus. // FEBS Letters, 1998, v. 438, p. 106−110.
- Joshi M.B., Gam A.A., Boykins R.A., et al. Immunogenicity of Well-characterized Synthetic Plasmodium falciparum Multiple Antigen Peptide Conjugates. — Infect Immun., 2001, v. 69, pp. 4884−4890.
- Taubman M.A., Smith D.J., Holmberg C.J., Eastcott J.W. Coimmunization with complementary glucosyltransferase peptides results in enhanced immunogenicity and protection against dental caries. // Infect Immun, 2000, v. 68, p. 2698−2703.
- Rose K., Zeng W., Brown L.E., Jackson D.C. A synthetic peptide-based polyoxime vaccine construct of high purity and activity. // Mol. Immunol., 1995, v.32, p. 1031−1309.
- Wiesmuller K.-H., Freund S., Jung G. Novel FMDV vaccine consisting of a T-cell epitope and B-cell activating terminus of E. coli lipoprotein: synthesis, results of vaccination and molecular dynamics. // Immunobiol., 1988, v. 177, p. 158−161.
- Prass W., Ringsdorf H., Bessler W., Wiesmuller K.H., Jung G. Lipopeptides of the N-terminus of E. coli lipoprotein: synthesis, mitogenicity and properties in monolayer experiments. // Biochim. Biophis. Acta, 1987, v. 900, p. 116−128.
- Jung G. Synthesis and perspectives of new adjuvants and carriers systems for potential application for synthetic vaccines. Synthetic antigens. // Ann. Scalvo., 1984, N 2, p. 191−208.
- Hoffman P., Heihle S., Shade U., Loppnow H., Ulmer A.J., Flad H.D., Jung G., Bessler W.G. Stimulation of human and murine adherent cells by bacterial lipoproteinvand synthetic lipopeptide analogues.//Immunobiol., 1988, v. 177, p. 158−170.
- ΠΠ΅ΡΡΠΎΠ² P.B., Π₯Π°ΠΈΡΠΎΠ² P.M. ΠΡΠΊΡΡΡΡΠ²Π΅Π½Π½ΡΠ΅ Π°Π½ΡΠΈΠ³Π΅Π½Ρ ΠΈ Π²Π°ΠΊΡΠΈΠ½Ρ. Π., ΠΠ΅Π΄ΠΈΡΠΈΠ½Π°, 1988, Ρ. 288.
- Wiesmuller Π.-Π., Bessler W., Jung G. Synthesis of the mitogenic S-2,3-bis (palmitoyloxy)propyl.-N-palmitoylpentapeptide from Escherihia coli lipoprotein. // Hoppe-Seyler s Z. Phisiol. Chem., 1983, v. 364, p. 593−606.
- Nardelli Π., Defoot J.-P., Huang W., Tam J. Design of a complete synthetic peptide-based AIDS vaccine with a built-in adjuvant. // AIDS Res. Hum. Retroviruses, 1992, v. 8, p. 1405−1407.
- Langhans Π., Braunschweiger I., Schweitzer S., Jung G., Inchauspe G., Sauerbruch Π’., Spengler U. Lipidation of T helper sequences from hepatitis Π‘ virus core significantly enhances T- cell activity in vitro. // Immunology, 2001, v. 102, p. 460−465.
- Wiesmuller K.-H., Jung G. and Hess G. Novel low-molecular-weight synthetic vaccine against foot-and-mouth disease containing a potent B-cell and macrophage activator. // Vaccine, 1989, v. 7, p. 29−33.
- Beck-Sickinger A.G., Rotering H., Wiesmuller K.H., Dorner F., Jung G. Mapping of antigenic and immunogenic sites of Haemophilus influenzae outer membrane protein P6 using synthetic lipopeptides. // Biol. Chem. Hoppe Seyler, 1994, v. 375, p. 173−182.
- Deres K., Schild H., Wiesmuller K.-H., Jung G., Rammensee H.G. In vivo priming of virus-specific cytotoxic T limphocytes with synthetic lipopeptide vaccine. //Nature, 1989, v. 342, p. 561−564.
- Rouaix F., Grass-Masse H., Mazingue C., Diesis E., Ridel P.R., Estaquier J., Capron A., Tartar A., Auriault C. Effect of a lipopeptidic formulation on macrophage activation and peptide presentation to T cells. // Vaccine, 1994, v. 12, p. 1209−1214.
- Huang W., Nardelli Π., Tam J. Lipophillic multiple antigen peptide system for peptide immunogen and synthetic vaccine. // Mol. Immunol., 1994, v. 31, p. 1191−1199.
- Benmohamed L., Krishnan R., Auge C., Primus J.F., Diamond D.J. Intranasal administration of a synthetic lipopeptide without adjuvant induces systemic immune responses. // Immunol., 2002, v. 106, p. 113−121.
- Gomara M.J., Riedemarm S., Vega I., Ibarra H., Ercilla G., ΠΠ°Π³ΠΎ I. Use of linear and multiple antigenic peptides in the immunodiagnosis of acute hepatitis A virus infection. // J. Immunol. Methods, 2000, v. 3, p. 23−34.
- Horvath A., Olive C., Wong A., Clair Π’., Yarwood P., Good M. and Toth I. Lipoamino acid-based adjuvant carrier system: enhanced immunogenicity of group a streptococcal peptide epitopes. //J. Med. Chem., 2002, v. 45, p.1387−1390.
- P.M. Π₯Π°ΠΈΡΠΎΠ², Π. Π‘. ΠΡΡΠΈΠ½, Π. Π. ΠΠΈΠ½Π΅Π³ΠΈΠ½, Π. Π. ΠΠ΅Π±ΡΠ΅Π². Π ΡΠΊΠΎΠ²ΠΎΠ΄ΡΡΠ²ΠΎ ΠΏΠΎ ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΠΎΠΌΡ (Π΄ΠΎΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΌΡ) ΠΈΠ·ΡΡΠ΅Π½ΠΈΡ Π½ΠΎΠ²ΡΡ ΡΠ°ΡΠΌΠ°ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ Π²Π΅ΡΠ΅ΡΡΠ², Π., «ΠΠ΅Π΄ΠΈΡΠΈΠ½Π°», 2000, Ρ. 257.
- Volpina Π.Π., Gelfanov V.M., Yarov A.V., Surovoy A.Yu., Chepurkin A.V., Ivanov V.T. New virus-specific T-helper epitopes of foot-and-mouth disease viral VPi protein. // FEBS Let. 1993. V. 333. P. 175−178.
- ΠΠΎΠ»ΠΊΠΎΠ²Π° Π’.Π., O.M. ΠΠΎΠ»ΡΠΏΠΈΠ½Π°, B.T. ΠΠ²Π°Π½ΠΎΠ², Π‘. Π. Π ΡΠ±ΠΈΠ½, Π. Π. Π‘Π΅ΠΌΠ°ΡΠΊΠΎ, Π. Π‘. ΠΠ°ΡΠ°Π²Π°Π½ΠΎΠ². ΠΠ·ΡΡΠ΅Π½ΠΈΠ΅ Π°Π½ΡΠΈΠ³Π΅Π½Π½ΠΎΠΉ ΡΡΡΡΠΊΡΡΡΡ Π²ΠΈΡΡΡΠ° ΠΊΠ»Π΅ΡΠ΅Π²ΠΎΠ³ΠΎ ΡΠ½ΡΠ΅ΡΠ°Π»ΠΈΡΠ° Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΡΠΈΠ½ΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ ΠΏΠ΅ΠΏΡΠΈΠ΄ΠΎΠ². // ΠΠΈΠΎΠΎΡΠ³Π°Π½, Ρ ΠΈΠΌΠΈΡ. 1998. Π’.24. Π‘. 100−111.
- ΠΠΎΠ»ΠΊΠΎΠ²Π° Π’.Π., ΠΠΎΠ»ΡΠΏΠΈΠ½Π° Π. Π., ΠΠΌΠ°ΠΊ Π. Π., ΠΠ²Π°Π½ΠΎΠ² Π. Π’., ΠΠΎΡΠΎΠ²ΠΈΡ Π. Π€., Π’ΠΈΠΌΠΎΡΠ΅Π΅Π² Π. Π. Π‘ΠΈΠ½ΡΠ΅Π·, ΠΈΠΌΠΌΡΠ½ΠΎΠ³Π΅Π½Π½ΡΠ΅ ΠΈ Π°Π½ΡΠΈΠ³Π΅Π½Π½ΡΠ΅ ΡΠ²ΠΎΠΉΡΡΠ²Π° ΡΡΠ°Π³ΠΌΠ΅Π½ΡΠΎΠ² Π³Π»ΠΈΠΊΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½Π° Π Π²ΠΈΡΡΡΠ° ΠΊΠ»Π΅ΡΠ΅Π²ΠΎΠ³ΠΎ ΡΠ½ΡΠ΅ΡΠ°Π»ΠΈΡΠ°. // ΠΠΈΠΎΠΎΡΠ³Π°Π½, Ρ ΠΈΠΌΠΈΡ, 2001. Π’.27. Π‘.174−179.
- ΠΠ΅Π»ΡΠ²ΠΈΠ³ Π.Π., Π‘Π΅ΠΌΠ΅Π½ΠΎΠ² Π. Π€. // ΠΡΡΠ½. ΠΌΠΈΠΊΡΠΎΠ±ΠΈΠΎΠ». 1997. № 6. Π‘. 92−96.
- Christodoulides M., Heckels J.E. Immunization with a multiple antigen peptide containing defined B- and T-cell epitopes: production of bactericidal antibodies against group Π Neisseria meningitidis. II Microbiol., 1994, v. 140, p. 2951−2960.
- Strohmaier K., Franze R., Adam K.H. Location and characterization of the antigenic portion of the FMDV immunizing protein. // J. Gen. Virol., 1982, v.59, p.295−306.
- Brett S.J., Cease Π.Π., Berzofsky A.J. Influences of antigen processing on the expression of the T cell repertoire. Evidence for ΠΠΠ‘-specific hindering structures on the products of processing. //J.Exp. Med. 1988. V. 168. P. 357−373
- Collen Π’., Dimarchi R, Doel T.R. A T cell epitope in VPI of foot-and-mouth disease virus is immunodominant for vaccinated cattle. // J. Immunol. 1991. V.146 P. 749−755.
- Mulcahy G., Gale C., Robertson P., Iyisan S., DiMarchi R.D., Doel T.R. Isotype responses of infected, virus-vaccinated and peptide-vaccinated cattle to foot-and-mouth disease virus. // Vaccine 1990. V.8. P. 249−256.
- DiMarchi R., Brooke G., Gale C., Cracknell V., Doel Π’., Mowast N. Protection of cattle against foot-and-mouth disease by a synthetic peptide. // Science 1986. V.232. P. 639−641.
- ΠΠ°Π»ΡΡΠ΅Ρ Π.Π. Π‘Π΅Π»ΡΡΠΊΠΎΠ΅ Ρ ΠΎΠ·ΡΠΉΡΡΠ²ΠΎ Π·Π° ΡΡΠ±Π΅ΠΆΠΎΠΌ. ΠΠΈΠ²ΠΎΡΠ½ΠΎΠ²ΠΎΠ΄ΡΡΠ²ΠΎ. 1973. № 2. Π‘. 29−33.
- A.V. Chepurkin, A.S. Toloknov, V.T. Ivanov. A peptide construct containing B-cell and T-cell epitopes from the foot-and-mouth disease viral VPi protein induces efficient antiviral protection, // Vaccine, 1999, 17,577−584
- M.A. ΠΡΠΏΡΠΈΡΠ½ΠΎΠ²Π°, M.H. ΠΠΌΠ°ΠΊ, Π. Π. ΠΠΎΡΠΎΠ΅Π², Π. Π. Π§Π΅ΠΏΡΡΠΊΠΈΠ½, Π. Π. ΠΠΎΠ»ΡΠΏΠΈΠ½Π°,
- B.Π’. ΠΠ²Π°Π½ΠΎΠ². Π‘ΠΈΠ½ΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΠ΅ΠΏΡΠΈΠ΄Π½ΡΠ΅ ΠΊΠΎΠ½ΡΡΡΡΠΊΡΠΈΠΈ Π½Π° ΠΎΡΠ½ΠΎΠ²Π΅ ΠΈΠΌΠΌΡΠ½ΠΎΠ°ΠΊΡΠΈΠ²Π½ΡΡ ΡΡΠ°Π³ΠΌΠ΅Π½ΡΠΎΠ² Π±Π΅Π»ΠΊΠ° VPi Π²ΠΈΡΡΡΠ° ΡΡΡΡΠ° ΡΡΠ°ΠΌΠΌΠ° Π22. // ΠΠΈΠΎΠΎΡΠ³Π°Π½, Ρ ΠΈΠΌΠΈΡ, 2000,26,926.
- Mishel Π.Π., Shady Π‘.Π. Selected methods in cellular immunology, Ed. W.H. Freeman, San Francisko. 1979. P. 281−296.